Green Growth
Regulation

Hemp in Brazil in 2026: what is regulated and what is not yet

Brazil opened medical hemp cultivation between 2024 and 2026. What is allowed, who may grow it and which uses still have no rules.

Short answer

Since August 4, 2026, companies in Brazil may grow hemp with up to 0.3% THC, with a Special Authorization from ANVISA and only for medical and pharmaceutical purposes (RDC 1.013/2026). Individuals may not grow it. Industrial uses such as fiber, construction, food and bioenergy still have no rules: the Superior Court of Justice noted there is no legal basis for them, and the Agriculture Ministry acknowledged the gap in a 2026 technical note.

What changed between 2024 and 2026

Three decisions, by three different bodies, changed where hemp stands under Brazilian law.

November 2024, Superior Court of Justice (STJ). In Incident of Assumption of Jurisdiction 16 (IAC 16), the court's First Section ruled that hemp, the variety of Cannabis sativa with less than 0.3% THC, cannot be treated as a banned plant. It allowed health authorizations for planting, growing, processing and selling by legal entities, for exclusively medical and pharmaceutical purposes, and ordered the federal government and ANVISA, the health regulator, to issue rules. In the same ruling, it noted there is no legal basis for other industrial uses.

2025, Agriculture Ministry (MAPA). The ministry published Ordinance 1.342/2025, setting the phytosanitary requirements for importing Cannabis sativa seeds. It was the first rule in the work plan agreed between the federal government and the STJ.

February 2026, ANVISA. On February 3, the Official Gazette published the package of resolutions that now organizes the sector. Each rule has its own effective date:

Rule What it covers In force since
RDC 1.011/2026 Adds cultivation by legal entities to the activities that require a Special Authorization August 4, 2026
RDC 1.012/2026 Cultivation for scientific research, with no THC limit August 4, 2026
RDC 1.013/2026 Hemp cultivation with up to 0.3% THC for medical and pharmaceutical purposes August 4, 2026
RDC 1.014/2026 Experimental regulatory sandbox of up to five years February 3, 2026
RDC 1.015/2026 Manufacturing, import and sale of cannabis products; replaces RDC 327/2019 May 4, 2026

Who may grow, and on what terms

RDC 1.013/2026 is the rule that matters to anyone thinking about planting. It requires:

  • A legal entity. Cultivation is a company activity. ANVISA states in its guidance that there is no legal basis for cultivation by individuals.
  • A Special Authorization (AE) from ANVISA, granted after a prior health inspection of the site.
  • THC content of up to 0.3%. Growing above that limit requires prior approval and additional requirements.
  • Traceability from seed to batch, with security controls.
  • An end use in the manufacture of registered medicines or authorized cannabis products.

In practice, farmers enter the chain through an authorized company, either their own or a partner that contracts the production. The authorization belongs to the company, not to the land or the grower.

What the finished product may be

RDC 1.015/2026 defines what leaves the factory. The permitted routes of administration are now oral, inhaled, buccal, sublingual and dermatological. Cosmetics, smokable products, medical devices and Cannabis sativa-based food are outside the scope of the rule.

Two points are often missed:

  • The Health Authorization has a use-by window. The authorized product must reach the market within one year of approval, or the authorization is cancelled.
  • Compounded CBD was provided for but does not work yet. It depends on a specific ANVISA rule on compounding good practices.

The sandbox is not a commercial shortcut

RDC 1.014/2026 created an experimental regulatory environment that lasts up to five years from the start of each project. It covers small-scale, non-commercial activities, with entry through a public call. Only legal entities incorporated in Brazil for at least two years may apply, and taking part does not guarantee a permanent authorization at the end.

Anyone looking for a way to test a business model should look at RDC 1.013 and RDC 1.015, not the sandbox.

What still has no rules

Textile fiber, pulp, construction (such as hempcrete), bioplastics, food, animal feed and bioenergy from hemp still have no regular path in Brazil. There are two different reasons:

  1. Industrial uses outside health lack a legal basis, as the STJ noted in IAC 16.
  2. Cosmetics and food were expressly left out of RDC 1.015.

In 2026, a MAPA technical note acknowledged the regulatory gap for industrial hemp and proposed guidelines for the crop: a THC-based definition, agricultural authorization and licensing, traceability, inspection and a mandatory industrial end use. It is a proposal, not a rule in force.

What to watch in the coming months

This section is Green Growth's reading, not settled fact.

  • The MAPA rule for industrial hemp. It could open fiber, grain and biomass to agribusiness and change the scale of the sector.
  • The 0.3% THC limit. A technical note by researchers from Embrapa and the Ficus Institute, with the National Industrial Hemp Association, suggests Brazil review whether this parameter fits tropical conditions. Supporters of a change argue for 1.0% in the field. If the limit moves, the economics of open-field cultivation move with it.
  • The sandbox call and the compounding rule, which would put into effect two provisions already written into the RDCs.

Frequently asked questions

Can individuals grow hemp in Brazil?

No. RDC 1.013/2026 allows cultivation only by legal entities with a Special Authorization from ANVISA. ANVISA itself states there is no legal basis for cultivation by individuals.

Can a company grow hemp for fiber or construction?

Not yet. Cultivation authorized under RDC 1.013/2026 is for medical and pharmaceutical purposes only. The STJ noted there is no legal basis for other industrial uses, and MAPA is still discussing a rule for industrial hemp.

Can the RDC 1.014 sandbox be used to test a business?

Not as a commercial model. The sandbox covers small-scale, non-commercial experimental projects, lasting up to five years, with entry through a public call.

Sources

For information only. Not a substitute for case-by-case legal analysis and not investment advice.